Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 109,407	$ 176,498
Prepaid expenses and other current assets	2,903	2,246
Total current assets	112,310	178,744
Property and equipment, net	126	91
Other assets	1,512	698
Total assets	113,948	179,533
Current liabilities
Accounts payable and accrued expenses	12,410	19,514
Total current liabilities	12,410	19,514
Total liabilities	12,410	19,514
Commitments and contingencies (Note 9)
Redeemable noncontrolling interest		11,663
Shareholders' Equity
Class A Ordinary Shares, $0.0001 par value; 300,000,000 shares authorized as of December 31, 2025 and 2024; 73,680,710 and 65,297,530 shares issued and outstanding as of December 31, 2025 and 2024, respectively	7	7
Additional paid-in capital	326,078	302,705
Accumulated deficit	(224,547)	(155,897)
Total Zura Bio Limited shareholders' equity	101,538	146,815
Noncontrolling interest		1,541
Total shareholders' equity	101,538	148,356
Total liabilities, redeemable noncontrolling interest and shareholders' equity	$ 113,948	$ 179,533